Search results for "hospitalization"

showing 10 items of 463 documents

Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors

2012

The H1N1 influenza pandemic strain has been associated with a poor prognosis in hospitalized patients. The present report evaluates the factors influencing prognosis.A total of 813 patients hospitalized with H1N1 influenza in 36 hospitals (nationwide) in Spain were analysed. Detailed histories of variables preceding hospital admission were obtained by interview, validating data on medications and vaccine with their attending physicians. Data on treatment and complications during hospital stay were recorded. As definition of poor outcome, the endpoints of death and admission to intensive care were combined; and as a further outcome, length of stay was used.The mean age was 38.5 years (SD 22.…

Malemedicine.disease_causeInfluenza A Virus H1N1 SubtypepreventionPregnancyInfluenza A virusPharmacology (medical)Young adultChildOriginal ResearchAged 80 and overNeuraminidase inhibitorbiologyMiddle AgedPrognosisHospitalizationInfectious DiseasesChild PreschoolFemaleMicrobiology (medical)Adultmedicine.medical_specialtyAdolescentCritical Caremedicine.drug_classNeuraminidaseadverse outcomesAntiviral AgentsYoung Adultlength of stayInternal medicineDiabetes mellitusIntensive careInfluenza HumanmedicineHumansSurvival analysisAgedPharmacologyPregnancyflubusiness.industrypandemicInfant NewbornInfantLength of Staymedicine.diseaseSurvival AnalysisSpainImmunologybiology.proteinbusinessNeuraminidase
researchProduct

Validity of the Seattle Heart Failure Model after heart failure hospitalization.

2019

Abstract Aims Heart failure hospitalization is a sentinel event associated with increased mortality risk. Whether long‐term heart failure risk models such as the Seattle Heart Failure Model (SHFM) accurately assess risk in the post‐hospital setting is unknown. Methods and results The SHFM was applied to a cohort of 2242 consecutive patients (50% women; mean age 73) on discharge after acute heart failure hospitalization and analysed for the primary endpoint of all‐cause mortality. Model discrimination and calibration were assessed. Direct patient‐level comparison between our study cohort and the original SHFM cohorts was also performed to confirm and quantify the degree and extent of increas…

Malemedicine.medical_specialty030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsSeattle Heart Failure ModelInternal medicineOriginal Research ArticlesClinical endpointmedicineHumansIn patient030212 general & internal medicineOriginal Research ArticleHospital dischargeMortality riskAgedAged 80 and overHeart FailureModels StatisticalReceiver operating characteristicbusiness.industryReproducibility of ResultsAcute heart failureMean ageAfter dischargeMiddle Agedmedicine.diseaseHospitalizationHeart failureAmbulatoryCohortCardiologyFemaleCardiology and Cardiovascular MedicinebusinessESC heart failure
researchProduct

Serum neprilysin and recurrent hospitalizations after acute heart failure

2016

Malemedicine.medical_specialty030204 cardiovascular system & hematologyPatient ReadmissionCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumans030212 general & internal medicineProspective StudiesNeprilysinAgedAged 80 and overHeart Failurebusiness.industryMiddle Agedmedicine.diseaseHospitalizationEchocardiographyHeart failureCardiologyFemaleNeprilysinCardiology and Cardiovascular MedicinebusinessBiomarkers
researchProduct

Clinical profile and 1-year clinical outcomes of super elderly patients admitted with acute heart failure

2020

There is scarce information about the clinical profile and prognosis of acute heart failure (AHF) at the extreme ranges of age. We aimed to evaluate the 1-year death (all-cause mortality and HF-death) and HF-rehospitalizations of patients ≥85 years admitted for AHF.We prospectively evaluated a cohort of 3054 patients admitted with AHF from 2007 to 2018 in a third-level center. Age was categorized per 10-year categories (65 years; 65-74 years, 75-84 years, and ≥85 years). The risk of mortality and HF-rehospitalizations across age categories was evaluated with Cox regression analysis and Cox regression adapted for competing events as appropriate.The mean age was 73.6 ± 11.2 years, 48.9% were …

Malemedicine.medical_specialty030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineHumansMedicine030212 general & internal medicineChildAgedAged 80 and overHeart FailureEjection fractionbusiness.industryFemale sexStroke VolumeMean ageMiddle AgedPrognosismedicine.diseaseHospitalizationIncreased riskHeart failureCohortFemalebusinessAll cause mortalityEuropean Journal of Internal Medicine
researchProduct

Homocysteine and long-term recurrent infarction following an acute coronary syndrome.

2021

En Cardiology Journal. Gdańsk (Polonia) : Via Medica. Vol. 28, n. 4 (01 jul. 2021), pp. 598-606. ISSN 1897-5593. e-ISSN 1898-018X. Este artículo se encuentra disponible en la siguiente URL: https://journals.viamedica.pl/cardiology_journal/article/view/CJ.a2020.0170/52602 En este artículo de investigación también participan: Maria Marco, Teresa García-Ballester, Begoña Zorio, Eduardo Núñez, Francisco J. Chorro, Juan Sanchis y Julio Núñez. Background: There are no well-established predictors of recurrent ischemic coronary events after an acute coronary syndrome (ACS). Higher levels of homocysteine have been reported to be associated with an increased atherosclerotic burden. The primary endpoi…

Malemedicine.medical_specialtyAcute coronary syndromeHomocysteinemedicine.medical_treatmentCoronary heart disease - Risk factors.Infarto de miocardio - Factores de riesgo.Enfermedad coronaria - Factores de riesgo.InfarctionClinical CardiologyRevascularizationCoronary artery diseasechemistry.chemical_compoundInterquartile rangeRisk FactorsInternal medicineMyocardial infarction - Risk factors.medicineHumansMyocardial infarctionAcute Coronary SyndromeHomocysteineAgedacute coronary syndrome coronary artery disease homocysteine recurrent myocardial infarction risk factorsCardiovascular system - Diseases - Risk factors.Framingham Risk Scorebusiness.industryEnfermedades cardiovasculares - Factores de riesgo.General Medicinemedicine.diseaseHospitalizationchemistryCardiologyST Elevation Myocardial InfarctionCardiology and Cardiovascular MedicinebusinessCardiology journal
researchProduct

Prognosis and Management of Acute Coronary Syndrome in Spain in 2012: The DIOCLES Study

2015

Abstract Introduction and objectives To identify the current mortality and management of patients admitted for suspected acute coronary syndrome in Spain. The last available registry (2004-2005) reported an in-hospital mortality of 5.7%. Methods The study included patients consecutively admitted between January and June 2012 at 44 hospitals selected at random. Information was collected on clinical course at admission and on events at 6 months. Results A total of 2557 patients admitted with suspected acute coronary syndrome were included: 788 (30.8%) with ST-segment elevation, 1602 (62.7%) without ST-segment elevation, and 167 (6.5%) with unclassified acute coronary syndrome. In-hospital mor…

Malemedicine.medical_specialtyAcute coronary syndromePercutaneousmedicine.medical_treatmentCoronary AngiographyBalloon inflationElectrocardiographyInternal medicinemedicineHumansHospital MortalityRegistriesAcute Coronary SyndromeAgedRetrospective StudiesAged 80 and overManagement of acute coronary syndromebusiness.industryIncidenceClinical courseDisease ManagementPercutaneous coronary interventionGeneral MedicineThrombolysisMiddle AgedPrognosismedicine.diseaseFrequent useHospitalizationCross-Sectional StudiesSpainCardiologyFemalebusinessFollow-Up StudiesRevista Española de Cardiología (English Edition)
researchProduct

Combining Disability and Frailty in an Integrated Scale for Prognostic Assessment After Acute Coronary Syndrome

2018

Malemedicine.medical_specialtyAcute coronary syndromeScale (ratio)Risk AssessmentSeverity of Illness IndexCohort StudiesDisability EvaluationPredictive Value of TestsCause of DeathmedicineHumansHospital MortalityAcute Coronary SyndromeGeriatric AssessmentAgedAged 80 and overFrailtybusiness.industryGeneral MedicinePrognosismedicine.diseaseSurvival AnalysisHospitalizationSpainPhysical therapyFemalebusinessRevista Española de Cardiología (English Edition)
researchProduct

An innovative lipid-lowering approach to enhance attainment of low-density lipoprotein cholesterol goals

2020

Aims To improve attainment of LDL-cholesterol (LDL-c) targets, an expert group proposed an algorithm for lipid-lowering therapy during hospitalization for acute coronary syndrome and during follow-up. We aimed to assess adherence to this algorithm, and evaluate its impact on LDL-c levels and on attainment of therapeutic LDL-c targets in a population of post-acute coronary syndrome patients. Methods and results Prospective, observational study including patients admitted for acute coronary syndrome between February 2017 and September 2018. Patients admitted without statins or ezetimibe were considered ‘naïve’. Baseline LDL-c was admission LDL-c in naïve patients, and for those taking lipid-…

Malemedicine.medical_specialtyAcute coronary syndromeStatinmedicine.drug_classLow density lipoprotein cholesterol030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineLipid-lowering therapy03 medical and health sciences0302 clinical medicineEzetimibeInternal medicinemedicineHumansProspective Studies030212 general & internal medicineAcute Coronary SyndromeAgedbusiness.industryAnticholesteremic AgentsCholesterol LDLGeneral MedicineEzetimibePrognosismedicine.diseaseExpert groupHospitalizationCardiologyPatient ComplianceLDL Cholesterol LipoproteinsFemalelipids (amino acids peptides and proteins)Lipid loweringCardiology and Cardiovascular MedicinebusinessAlgorithmsBiomarkersFollow-Up Studiesmedicine.drugEuropean Heart Journal. Acute Cardiovascular Care
researchProduct

Sex-differential effect of frailty on long-term mortality in elderly patients after an acute coronary syndrome.

2020

Background The potential sex-differential effect of frailty in patients with acute coronary syndromes (ACS) has not been well-evaluated. We sought to examine the sex-differential association between frailty status on long-term mortality in elderly patients with an ACS. Methods and results This is a prospective observational single-center study that included 488 elderly patients (>65 years) hospitalized for ACS who survived the index hospitalization. Multivariate Cox regression was used to determine the association among the exposures (interaction of sex with Fried score and sex with Fried ≥ 3) and all-cause mortality. The mean age of the sample was 78 ± 7 years; 41% were female and the medi…

Malemedicine.medical_specialtyAcute coronary syndromeTime Factorsfrailty030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineSex FactorsInternal medicinemedicineHumansacute coronary syndromesIn patient030212 general & internal medicineProspective StudiesAcute Coronary SyndromeSex DistributionAgedFrailtyProportional hazards modelbusiness.industryIncidenceAge FactorsMean agemedicine.diseasePrognosisSurvival RateSpainLong term mortalityObservational studyFemalewomenprognosisCardiology and Cardiovascular MedicinebusinessIndex hospitalizationFollow-Up StudiesInternational journal of cardiology
researchProduct

Incidence of curvature progression in idiopathic scoliosis patients treated with scoliosis in-patient rehabilitation (SIR): an age- and sex-matched c…

2003

The goal of this study is to test the hypothesis that physiotherapy-based intervention can reduce incidence of progression in children with IS. Two independent patient groups matched by age and sex at diagnosis were analysed using the outcome parameter, incidence of progression (or =5 degrees ). One group was untreated and the other received scoliosis in-patient rehabilitation (SIR). Incidence of progression in groups of untreated patients ranged from 1.5-fold (71.2% vs 46.7%) to 2.9-fold (55.8% vs 19.2%) higher than in groups of patients treated with SIR, even when SIR-treated groups included patients with more severe curvatures. Statistically, the differences were highly significant. Effo…

Malemedicine.medical_specialtyAdolescentMatched-Pair Analysismedicine.medical_treatmentScoliosisAge and sexSex FactorsInternal medicineEpidemiologymedicineHumansIn patientChildRehabilitationbusiness.industryIncidenceIncidence (epidemiology)RehabilitationAge Factorsmedicine.diseaseExercise TherapySurgeryHospitalizationNatural historyScoliosisEl NiñoPediatrics Perinatology and Child HealthDisease ProgressionFemalebusinessPediatric Rehabilitation
researchProduct